Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1323885 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $40.89Day +2.87%Mkt cap $2.1B1Y +28.9%Off 52W high −5.3%Vol (1Y) 48.0%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,274 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest9.6% of sh out |
| Days to cover5.7d |
| 13F net flow (QoQ)+1.91% |
| Top-10 13F concentration49.8% |
| Next report (est.)2026-10-22 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$569.6M |
| Earnings (TTM)$10.6M |
| ROE−2.4% |
| Net margin−2.1% |
| ROIC−1.9% |
| Debt / equity0.13× |
| Sales growth 3Y17.4% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+3.4% |
| 1Y+28.9% |
| 3Y−26.1% |
| 5Y−51.1% |
| 10Y+169.2% |
| Since incept. (ann.)+5.2% |
Total return through 2026-07-29 · series begins 2005-08-05. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)48.0% |
| Ann. volatility (3Y)48.3% |
| Sharpe (1Y)0.68 |
| Sharpe (3Y)0.03 |
| Max drawdown (1Y)−39.0% |
| Max drawdown (3Y)−65.3% |
| Beta (3Y vs SPY)0.86 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 3.3M | $129M | 6.41% | −8.6% |
| BlackRock, Inc. | 4.0M | $115M | 7.95% | −0.6% |
| WELLINGTON MANAGEMENT GROUP LLP | 3.4M | $97M | 6.65% | −13.7% |
| Hood River Capital Management LLC | 3.1M | $89M | 6.13% | +0.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.7M | $77M | 5.31% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $62M | 4.24% | new |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.8M | $51M | 3.55% | −11.5% |
| GOLDMAN SACHS GROUP INC | 1.7M | $48M | 3.28% | +88.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-06-30 | 2026-07-23 | $0.18 | — | $153.6M | +12.8% |
| 2026-03-31 | 2026-05-05 | $0.00 | — | $141.2M | +14.3% |
| 2025-12-31 | 2026-02-17 | — | — | $140.5M | +13.1% |
| 2025-09-30 | 2025-10-29 | −$0.01 | — | $134.3M | +15.8% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-10-22 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
US 69% · Non Us 16% · Europe 10% · Asia Pacific 5% · Other International 1%
geographic · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
